People who are diagnosed with head and neck cancer often receive a standard type of chemotherapy as part of their treatment. If they are exposed to secondhand smoke during chemotherapy — even if they have never smoked themselves — the treatment may be far less effective at killing cancer cells. That finding, considered the first of its kind, was revealed in a study recently published by researchers at the University of Oklahoma Health Sciences.

University of Oklahoma College of Medicine researcher Paul L. DeAngelis, Ph.D., has been awarded the President’s Innovator Award by the Society for Glycobiology.

New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia, a debilitating muscle-wasting condition that almost always occurs in people diagnosed with pancreatic cancer.

The University of Oklahoma’s Master of Health Administration and Policy — the only MHA degree program offered in Oklahoma — has been reaccredited for a seven-year term by the Commission on Accreditation of Healthcare Management Education.

Yuri Lansinger, M.D., associate professor with the Department of Orthopedic Surgery at the University of Oklahoma College of Medicine and a board-certified orthopedic surgeon specializing in hand surgery, has received the Fulbright U.S. Scholar award for the 2024-2025 academic year.